Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 124 for “"Cancer Vaccine"”.

  1. HER2/neu-specific Breast Cancer Vaccine

    Breast cancer is the most common cancer among women. Of all breast cancers cases, approximately 30 percent have amplification of the self-antigen HER2/neu. Later studies demonstrated that HER2/neu-specific antibody and T cell responses were found in HER2/neu-positive breast cancer patients, …

    sask Repository record for HER2/neu-specific Breast Cancer Vaccine (opens in a new tab)

  2. Improving Cancer Vaccine Design for Personalized Precision Oncology

    Innovative cancer immunotherapies, like cancer vaccines and T-cell-based therapies, have brought forth remission for many patients. However, there are concerns of safety risks, tumor evasion, and treatment failure. In the context of peptide-based cancer vaccines, there are limitations regarding …

    houston Repository record for Improving Cancer Vaccine Design for Personalized Precision Oncology (opens in a new tab) Embargoed until 2028-08-01

  3. NOVEL RNA-BASED CANCER VACCINE FOR AML IMMUNOTHERAPY

    … We hypothesize that personalized mRNA cancer vaccine can be a viable treatment strategy for AML patients. Using mouse AML cell lines, we have found candidate neoepitopes within intron polyadenylation sites, retained-intron sites, and somatic mutation sites. Screen for immunogenic …

    nus Repository record for NOVEL RNA-BASED CANCER VACCINE FOR AML IMMUNOTHERAPY (opens in a new tab) Download file for NOVEL RNA-BASED CANCER VACCINE FOR AML IMMUNOTHERAPY (opens in a new tab)

  4. Antigen-Loaded Monocytes as a Novel Cancer Vaccine

    … (DC) have been the key elements in developing cancer vaccines to induce potent T cell responses to eradicate tumors. However, the common approach adopted in clinical trials using ex vivo generated DC loaded with tumor antigens (Ag) has been challenged by its limited clinical response, …

    duke Repository record for Antigen-Loaded Monocytes as a Novel Cancer Vaccine (opens in a new tab)

  5. Developing combination therapy to improve viral vector cancer vaccine efficacy

    The development of effective cancer immunotherapies presents several major challenges that must be considered. Notably, it requires the generation of specific immune responses against cancer cells whilst counteracting the highly immunosuppressive mechanisms of the tumour microenvironment. …

    oxford Repository record for Developing combination therapy to improve viral vector cancer vaccine efficacy (opens in a new tab)

  6. INVESTIGATING MECHANISMS OF CANCER VACCINE-INDUCED TUMOR IMMUNITY AND AUTOIMMUNITY

    … employing immunotherapy as a strategy to treat cancer.</p> <p><strong>METHODS: </strong>Using the B16F10 murine melanoma model, we have been investigating mechanisms of T cell-mediated antitumor immunity following immunization with dopachrome tautomerase (DCT), a melanoma-associated antigen.</p> …

    mcmaster Repository record for INVESTIGATING MECHANISMS OF CANCER VACCINE-INDUCED TUMOR IMMUNITY AND AUTOIMMUNITY (opens in a new tab)

  7. Development and Characterization of an Autologous Whole Cell Breast Cancer Vaccine

    Approximately 40,000 women will die from breast cancer in the United States in 2014. About 90% of these deaths will be due to metastases, rather than the primary tumor and majority of metastases are due to the recurrence and progression of non-metastatic disease. Current adjuvant treatments, such …

    arkansas Repository record for Development and Characterization of an Autologous Whole Cell Breast Cancer Vaccine (opens in a new tab)

  8. Self-assembled Nanogel-based Antigen Carrier Systems for Therapeutic Cancer Vaccine

    付記する学位プログラム名: 充実した健康長寿社会を築く総合医療開発リーダー育成プログラム

    kyoto Repository record for Self-assembled Nanogel-based Antigen Carrier Systems for Therapeutic Cancer Vaccine (opens in a new tab)

  9. The feasibility to exploit fusion protein comprising Recoverin and HSP70 as cancer vaccine

    Cancer now is the leading cause of mortality worldwide. Despite the advances in conventional cancer treatments, like surgery and chemotherapy, the survival of cancer patients remains unsatisfying. Currently, immunotherapy, as a novel therapeutic alternative, exhibits a great efficacy to struggle …

    lmu-germany Repository record for The feasibility to exploit fusion protein comprising Recoverin and HSP70 as cancer vaccine (opens in a new tab)

  10. Validation and identification of tumour endothelial markers and their uses in cancer vaccine

    … holds therapeutic promise for the treatment of cancer. Differential gene expression analysis of freshly isolated lung tumour endothelium by 2nd generation sequencing identified 13 putative TEMs. Subsequent validation work confirmed six of which to be expressed on lung tumour vasculature. …

    birmingham Download PDF for Validation and identification of tumour endothelial markers and their uses in cancer vaccine (opens in a new tab)

  11. Liposomal Cancer Vaccine Development through Mimotope Screening, Immunostimulant Evaluation, and Immune Cell Targeting

    Cancer cells proliferate uncontrollably and can evade recognition or elimination by the immune system. Immunotherapy seeks to overcome this challenge by directing immune responses to specifically identify and destroy malignant cells. Among its approaches, major histocompatibility complex class I …

    buffalo Repository record for Liposomal Cancer Vaccine Development through Mimotope Screening, Immunostimulant Evaluation, and Immune Cell Targeting (opens in a new tab)

  12. Unique Phenotypic and Functional Properties of a Cancer Vaccine Based on Attenuated Listeria Monocytogenes

    … but have had limited success as therapeutic cancer treatments. We explored the differences in the cellular and molecular immunity generated by a new Listeria Monocytogenes vaccine platform, as compared to the well characterized Vaccinia Virus. Listeria-OVA vaccination resulted in the slowest …

    jhu Repository record for Unique Phenotypic and Functional Properties of a Cancer Vaccine Based on Attenuated Listeria Monocytogenes (opens in a new tab)

  13. Key Factors Influencing the Efficacy of a Cancer Vaccine Targeting a Tumor-Associated Self-Antigen

    Cancer is a complex and often deadly disease with an ever-increasing number of new diagnoses. While various immunotherapies have had some success mobilizing the immune system against tumors, many patients do not respond to currently available treatments. The ancer–immunity cycle describes the …

    zurich

  14. Sympathetic Nervous System Modulation of Cancer Vaccine Activity and Nanoparticle Drug Delivery for Limb Ischemia

    … nonspecific β-blocker propranolol with a peptide cancer vaccine for the treatment of melanoma in mice. We report the novel finding that norepinephrine treatment dramatically altered moMФ cytokine production and T cell priming, whereas DCs were unresponsive to norepinephrine and critically lack …

    tamu Repository record for Sympathetic Nervous System Modulation of Cancer Vaccine Activity and Nanoparticle Drug Delivery for Limb Ischemia (opens in a new tab)

  15. Human Endogenous Retrovirus K As A Novel Tumor-Associated Antigen For Development of An Ovarian Cancer Vaccine

    … ANTIGEN FOR DEVELOPMENT OF AN OVARIAN CANCER VACCINE Publication No.________Kiera Rycaj, B.S.Supervisory Professor: Feng Wang-Johanning, Ph.D., M.D. Ovarian cancer (OC) is the fourth most common cancer in women, and the most lethal gynecologic malignancy in the United States. Adequate …

    uthsc Repository record for Human Endogenous Retrovirus K As A Novel Tumor-Associated Antigen For Development of An Ovarian Cancer Vaccine (opens in a new tab)

  16. Engineering novel antibody-based molecules to probe the role of the immunoglobulin hinge and generate a potential cancer vaccine

    … a second IgG engineering approach, potential cancer vaccines that feature the Fc region of IgG fused to the tumour associated cancer-testis antigen, MAGE-A, were generated and tested. Such vaccines are designed to promote formation of immune complexes, which are preferentially taken up by …

    dundee Repository record for Engineering novel antibody-based molecules to probe the role of the immunoglobulin hinge and generate a potential cancer vaccine (opens in a new tab) Download PDF for Engineering novel antibody-based molecules to probe the role of the immunoglobulin hinge and generate a potential cancer vaccine (opens in a new tab)

Page 1 of 7